vs
Side-by-side financial comparison of CBAK Energy Technology, Inc. (CBAT) and ORTHOPEDIATRICS CORP (KIDS). Click either name above to swap in a different company.
ORTHOPEDIATRICS CORP is the larger business by last-quarter revenue ($61.6M vs $58.8M, roughly 1.0× CBAK Energy Technology, Inc.). CBAK Energy Technology, Inc. runs the higher net margin — -12.5% vs -16.4%, a 3.9% gap on every dollar of revenue. On growth, CBAK Energy Technology, Inc. posted the faster year-over-year revenue change (131.8% vs 17.0%). CBAK Energy Technology, Inc. produced more free cash flow last quarter ($16.1M vs $9.7M). Over the past eight quarters, ORTHOPEDIATRICS CORP's revenue compounded faster (17.4% CAGR vs -0.0%).
CBAK Energy Technology, Inc. is a global supplier of lithium-ion battery products including high-performance cells, modules and battery packs. It serves key segments such as electric vehicles, stationary energy storage systems and consumer electronics, with core operations in China and a worldwide customer base.
OrthoPediatrics is an American bio-science company engaged in designing, developing, manufacturing, and distributing orthopedic implants and instruments for pediatric issues. It is based in Warsaw, Indiana.
CBAT vs KIDS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $58.8M | $61.6M |
| Net Profit | $-7.4M | $-10.1M |
| Gross Margin | 7.3% | 73.2% |
| Operating Margin | -13.6% | -13.3% |
| Net Margin | -12.5% | -16.4% |
| Revenue YoY | 131.8% | 17.0% |
| Net Profit YoY | -63.6% | 37.1% |
| EPS (diluted) | $-0.08 | $-0.43 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $58.8M | $61.6M | ||
| Q3 25 | $60.9M | $61.3M | ||
| Q2 25 | $40.5M | $61.1M | ||
| Q1 25 | $34.9M | $52.4M | ||
| Q4 24 | $25.4M | $52.7M | ||
| Q3 24 | $44.6M | $54.6M | ||
| Q2 24 | $47.8M | $52.8M | ||
| Q1 24 | $58.8M | $44.7M |
| Q4 25 | $-7.4M | $-10.1M | ||
| Q3 25 | $2.7M | $-11.8M | ||
| Q2 25 | $-3.1M | $-7.1M | ||
| Q1 25 | $-1.6M | $-10.7M | ||
| Q4 24 | $-4.5M | $-16.1M | ||
| Q3 24 | $17.6K | $-7.9M | ||
| Q2 24 | $6.4M | $-6.0M | ||
| Q1 24 | $9.8M | $-7.8M |
| Q4 25 | 7.3% | 73.2% | ||
| Q3 25 | 8.0% | 73.9% | ||
| Q2 25 | 11.0% | 72.1% | ||
| Q1 25 | 13.7% | 73.0% | ||
| Q4 24 | 13.1% | 67.5% | ||
| Q3 24 | 15.6% | 73.4% | ||
| Q2 24 | 26.6% | 77.3% | ||
| Q1 24 | 31.9% | 72.0% |
| Q4 25 | -13.6% | -13.3% | ||
| Q3 25 | -6.6% | -15.4% | ||
| Q2 25 | -8.7% | -17.4% | ||
| Q1 25 | -8.2% | -21.0% | ||
| Q4 24 | -26.0% | -26.7% | ||
| Q3 24 | -1.9% | -10.2% | ||
| Q2 24 | 12.4% | -10.7% | ||
| Q1 24 | 17.4% | -21.8% |
| Q4 25 | -12.5% | -16.4% | ||
| Q3 25 | 4.4% | -19.2% | ||
| Q2 25 | -7.6% | -11.6% | ||
| Q1 25 | -4.5% | -20.3% | ||
| Q4 24 | -17.8% | -30.5% | ||
| Q3 24 | 0.0% | -14.5% | ||
| Q2 24 | 13.5% | -11.4% | ||
| Q1 24 | 16.7% | -17.5% |
| Q4 25 | $-0.08 | $-0.43 | ||
| Q3 25 | $0.03 | $-0.50 | ||
| Q2 25 | $-0.03 | $-0.30 | ||
| Q1 25 | $-0.02 | $-0.46 | ||
| Q4 24 | $-0.05 | $-0.70 | ||
| Q3 24 | $0.00 | $-0.34 | ||
| Q2 24 | $0.07 | $-0.26 | ||
| Q1 24 | $0.11 | $-0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $8.3M | $60.9M |
| Total DebtLower is stronger | $4.1M | $106.0M |
| Stockholders' EquityBook value | $112.7M | $346.6M |
| Total Assets | $426.2M | $508.6M |
| Debt / EquityLower = less leverage | 0.04× | 0.31× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $8.3M | $60.9M | ||
| Q3 25 | $10.5M | $57.7M | ||
| Q2 25 | $45.7M | $70.1M | ||
| Q1 25 | $9.6M | $58.8M | ||
| Q4 24 | $11.0M | $68.8M | ||
| Q3 24 | $24.2M | $76.1M | ||
| Q2 24 | $44.1M | $28.9M | ||
| Q1 24 | $23.8M | $47.7M |
| Q4 25 | $4.1M | $106.0M | ||
| Q3 25 | $4.8M | $105.3M | ||
| Q2 25 | $4.9M | $102.7M | ||
| Q1 25 | $4.1M | $77.4M | ||
| Q4 24 | — | $77.5M | ||
| Q3 24 | — | $76.9M | ||
| Q2 24 | — | $11.2M | ||
| Q1 24 | — | $11.3M |
| Q4 25 | $112.7M | $346.6M | ||
| Q3 25 | $121.4M | $349.3M | ||
| Q2 25 | $118.2M | $355.5M | ||
| Q1 25 | $120.8M | $347.1M | ||
| Q4 24 | $121.7M | $354.6M | ||
| Q3 24 | $131.2M | $370.9M | ||
| Q2 24 | $126.6M | $371.3M | ||
| Q1 24 | $120.9M | $370.6M |
| Q4 25 | $426.2M | $508.6M | ||
| Q3 25 | $363.9M | $493.5M | ||
| Q2 25 | $333.1M | $503.6M | ||
| Q1 25 | $311.5M | $470.3M | ||
| Q4 24 | $302.2M | $473.2M | ||
| Q3 24 | $293.5M | $489.3M | ||
| Q2 24 | $279.6M | $430.8M | ||
| Q1 24 | $286.5M | $437.2M |
| Q4 25 | 0.04× | 0.31× | ||
| Q3 25 | 0.04× | 0.30× | ||
| Q2 25 | 0.04× | 0.29× | ||
| Q1 25 | 0.03× | 0.22× | ||
| Q4 24 | — | 0.22× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.03× | ||
| Q1 24 | — | 0.03× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $29.8M | $10.3M |
| Free Cash FlowOCF − Capex | $16.1M | $9.7M |
| FCF MarginFCF / Revenue | 27.3% | 15.8% |
| Capex IntensityCapex / Revenue | 23.4% | 1.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $3.9M | $-16.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $29.8M | $10.3M | ||
| Q3 25 | $14.6M | $-581.0K | ||
| Q2 25 | $13.8M | $-10.5M | ||
| Q1 25 | $-9.6M | $-4.2M | ||
| Q4 24 | $9.6M | $-4.0M | ||
| Q3 24 | $19.7M | $-10.3M | ||
| Q2 24 | $2.9M | $-6.1M | ||
| Q1 24 | $7.4M | $-6.7M |
| Q4 25 | $16.1M | $9.7M | ||
| Q3 25 | $6.0M | $-3.4M | ||
| Q2 25 | $4.1M | $-13.9M | ||
| Q1 25 | $-22.3M | $-8.4M | ||
| Q4 24 | $3.9M | $-4.2M | ||
| Q3 24 | $16.5M | $-11.7M | ||
| Q2 24 | $2.5M | $-12.8M | ||
| Q1 24 | $-454.0K | $-13.2M |
| Q4 25 | 27.3% | 15.8% | ||
| Q3 25 | 9.9% | -5.6% | ||
| Q2 25 | 10.2% | -22.8% | ||
| Q1 25 | -63.9% | -16.0% | ||
| Q4 24 | 15.5% | -8.1% | ||
| Q3 24 | 37.1% | -21.4% | ||
| Q2 24 | 5.2% | -24.2% | ||
| Q1 24 | -0.8% | -29.4% |
| Q4 25 | 23.4% | 1.0% | ||
| Q3 25 | 14.1% | 4.6% | ||
| Q2 25 | 23.8% | 5.6% | ||
| Q1 25 | 36.3% | 8.1% | ||
| Q4 24 | 22.5% | 0.5% | ||
| Q3 24 | 7.0% | 2.5% | ||
| Q2 24 | 0.9% | 12.7% | ||
| Q1 24 | 13.4% | 14.5% |
| Q4 25 | — | — | ||
| Q3 25 | 5.51× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 1115.72× | — | ||
| Q2 24 | 0.46× | — | ||
| Q1 24 | 0.76× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CBAT
| Manufacturing Lithium Batteries | $28.0M | 48% |
| Residential Energy Supply And Uninterruptable Supplies | $17.8M | 30% |
| Light Electric Vehicles | $12.9M | 22% |
| Precursor | $108.0K | 0% |
KIDS
Segment breakdown not available.
